Global menu

Our global pages

Close

Eversheds comment: Pharmaceuticals’ concerns telling of wider UK industry/regulator tension

  • United Kingdom

    15-11-2013

    In response to calls from the pharmaceutical industry that the number of medicines being blocked from the UK market by the National Institute for Health and Care Excellence (NICE) is too high, Simon Crossley, partner and head of life sciences at global law firm, Eversheds, comments: 

    “With UK government austerity measures showing no signs of fading, there is an obvious tension between the pharmaceutical industry and NICE. While the industry understandably wants to access markets for new products, NICE effectively creates a further hurdle once clinical trials have been successful, to ensure that new medicines, made available through public funds, are assessed to ensure treatments are cost effective. NICE decisions are being regularly challenged by the industry in private and it’s telling that a group of companies have now gone public with their concerns, forcing NICE to justify its stance.”

    Simon Crossley, Partner

    This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

    < Go back

    Print Friendly and PDF

    © Eversheds Sutherland 2021. All rights reserved. Eversheds Sutherland is a global provider of legal and other services operating through various separate and distinct legal entities.

    Eversheds Sutherland is the name and brand under which the members of Eversheds Sutherland Limited (Eversheds Sutherland (International) LLP and Eversheds Sutherland (US) LLP) and their respective controlled, managed and affiliated firms and the members of Eversheds Sutherland (Europe) Limited (each an "Eversheds Sutherland Entity" and together the "Eversheds Sutherland Entities") provide legal or other services to clients around the world. Eversheds Sutherland Entities are constituted and regulated in accordance with relevant local regulatory and legal requirements and operate in accordance with their locally registered names. The use of the name Eversheds Sutherland, is for description purposes only and does not imply that the Eversheds Sutherland Entities are in a partnership or are part of a global LLP. The responsibility for the provision of services to the client is defined in the terms of engagement between the instructed firm and the client.